From Parent to Advocate: A Practical Guide

Many Duchenne families end up as advocates. Sometimes intentionally, sometimes because no one else was going to do the work. Advocacy can change clinical guidelines, screening programs, and research priorities, but it is also intense and emotionally demanding. This guide describes what parent advocacy in DMD typically looks like, how to start, and how to keep doing it without burning out.

Why parent advocacy has mattered in DMD

DMD is rare. Decisions about research funding, newborn screening, clinical trial design, and standards of care are shaped by people who pay sustained attention. Parents have been doing exactly that for decades.

A clear example is newborn screening. In December 2025, the U.S. Department of Health and Human Services added Duchenne to the Recommended Uniform Screening Panel, the national list of conditions recommended for newborn screening. The nomination package was submitted by Parent Project Muscular Dystrophy, with the Muscular Dystrophy Association as co-nominator, after more than a decade of state-based pilots and federal engagement. (PPMD, Duchenne added to the RUSP)

That outcome did not happen on its own. It happened because parents organized for years.

What advocacy can include

A practical, non-exhaustive list of common activities:

• Participating in patient organizations (PPMD, MDA, CureDuchenne, Jett Foundation, Duchenne UK, and many others).
• Joining patient registries that contribute to research.
• Contributing personal stories to patient-focused drug development processes at regulators such as the FDA.
• Attending or speaking at family conferences and clinical meetings.
• Reviewing clinical trial design from the patient perspective.
• Fundraising for research or family support programs.
• Supporting other families who are newer to the diagnosis.
• Reading and commenting on draft clinical guidelines when public comment is open.

These vary in scope, time commitment, and visibility. Most families do some, not all.

Working with patient organizations

Patient organizations exist for a reason. They have institutional memory, legal teams, communications staff, and relationships with clinicians, researchers, and regulators. Working through an established organization does not silence individual voices. It can amplify them, and it protects families from doing every part of the work alone.

The FDA’s patient-focused drug development work in DMD is one example of structured engagement. It collects patient and caregiver perspectives on disease burden, treatment goals, and acceptable risk, and feeds those into regulatory review. (FDA, Voice of the Patient DMD)

For families newer to advocacy, contacting a national organization is usually the most useful first step. They can match interests to active work.

What to think about before going public

Public advocacy changes a family’s exposure. Names, faces, and personal medical details may appear in interviews, social media, and public records.

A few questions to think through before that point:

• What does the child want, at the age where they can articulate it?
• Which medical details are shared, and which are not?
• Who in the family is comfortable being identified, and who is not?
• What is the goal: a specific change, fundraising, general awareness?

Clear answers reduce later regret.

Sustainability

Advocacy is a long game. Families who burn out early lose their seat at the table later.

What helps: rotating responsibilities between multiple people, taking actual breaks, separating personal life from advocacy work where possible, building a small advisory group of trusted clinicians and experienced advocates, and protecting time with the child and siblings.

For more on this, see caregiver burnout in DMD families.

What is still uncertain

Advocacy outcomes are rarely linear. Years of patient effort can produce little visible change, and then a single decision shifts the picture. Families cannot guarantee outcomes. They can choose to participate.

The reasonable goal is participation that fits the family’s life, not the other way around.

For related reading, see DMD patient advocacy history, newborn screening for DMD, and the reported pieces Children Waiting While Time Runs Out and When Time Is Stealing Your Child.

Disclaimer: This post is informational and does not constitute medical advice. Decisions about diagnosis or treatment must be made with a qualified care team.